Neurontin | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Neurontin
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Granules Gabapentin

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Neurontin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 34 USDMF, 27 CEP/COS, 1 JDMF, 14 EU WC, 59 KDMF, 33 NDC API, 39 Listed Suppliers, $ API Reference Price

77 API Suppliers
34 USDMF
27 CEP/COS
1 JDMF
14 EU WC
59 KDMF
33 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

759 FDF Dossiers, 171 FDA Orange Book, 349 Europe, 66 Canada, 49 Australia, 26 South Africa, 98 Listed Dossiers

759 FDF Dossiers
171 FDA Orange Book
349 Europe
66 Canada
49 Australia
26 South Africa
98 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 300MG, CAPSULE;ORAL - 400MG, TABLET;ORAL - 300MG, TABLET;ORAL - 450MG, TABLET;ORAL - 600MG, TABLET;ORAL - 750MG, TABLET;ORAL - 900MG

CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 300MG
CAPSULE;ORAL - 400MG
TABLET;ORAL - 300MG
TABLET;ORAL - 450MG
TABLET;ORAL - 600MG
TABLET;ORAL - 750MG
TABLET;ORAL - 900MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 24 SPI Pharma, 2 Seqens, 18 DKSH, 7 Faran Shimi Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 61 Coating Systems & Additives, 55 Direct Compression, 42 Thickeners and Stabilizers, 35 Solubilizers, 34 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 33 Granulation, 27 Taste Masking, 24 Parenteral, 23 Chewable & Orodispersible Aids, 22 Film Formers & Plasticizers, 22 Co-Processed Excipients, 21 Lubricants & Glidants, 21 Topical, 9 Empty Capsules, 9 Emulsifying Agents, 8 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

113 Fillers, Diluents & Binders
61 Coating Systems & Additives
55 Direct Compression
42 Thickeners and Stabilizers
35 Solubilizers
34 Controlled & Modified Release
34 Disintegrants & Superdisintegrants
33 Granulation
27 Taste Masking
24 Parenteral
23 Chewable & Orodispersible Aids
22 Film Formers & Plasticizers
22 Co-Processed Excipients
21 Lubricants & Glidants
21 Topical
9 Empty Capsules
9 Emulsifying Agents
8 Rheology Modifiers
7 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 60 NEWS #PharmaBuzz

7 DATA COMPILATION #PharmaFlow
60 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 282 Finished Drug Prices, 3 Annual Reports

3 US Medicaid Prescriptions
282 Finished Drug Prices
3 Annual Reports

MARKET PLACE

37 APIs, 8 FDF Dossiers

37 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 20 Health Canada Patents

2 US Patents
20 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 6 Others

4 EDQM
2 USP
6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 34 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2ALMATICA

filter Patent Number Reset all filters

2 All

01 27438927

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22024-02-26

Product Main Page

01

ALMATICA

Antibody Engineering

Not Confirmed

ALMATICA

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-02-26

US Patent Number : 7438927

Drug Substance Claim :

Drug Product Claim :

Application Number : 22544

Patent Use Code : U-1114

Delist Requested :

Patent Use Description : TREATMENT WITH GABAPEN...

Patent Expiration Date : 2024-02-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ALMATICA

Antibody Engineering

Not Confirmed

ALMATICA

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-02-26

US Patent Number : 7438927

Drug Substance Claim :

Drug Product Claim :

Application Number : 22544

Patent Use Code : U-1114

Delist Requested :

Patent Use Description : TREATMENT WITH GABAPEN...

Patent Expiration Date : 2024-02-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?